Ali Behbahani Transaction History

Date Transaction Value Shares Traded Form
Dec 04 2020
BUY
Open market or private purchase
$2,727,133 $0.62 p/Share
4,398,602

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
UTRS
MINERVA SURGICAL INC Healthcare
MTCR
Metacrine, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
ACLX
Arcellx, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SVRA
Savara Inc Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
AB

Ali Behbahani

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on RGLS

Follow Regulus Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

News

Receive news related to Regulus Therapeutics Inc.

Track Activities on RGLS